Steven G. Potkin

Steven G. Potkin

Auto-generated profile, based on publicly available information

Steven G. Potkin

Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, CA, USA

Research Focus & Metrics

Academic Career Length

50Years (1977-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in NeuroImage: Clinical
Verified
Journal Article
Open access
EDE. Damaraju
E. Damaraju
EAE.A. Allen
E.A. Allen
ABA. Belger
A. Belger
JFJ.M. Ford
J.M. Ford
SMS. McEwen
S. McEwen
VCV.D. Calhoun
V.D. Calhoun
Schizophrenia is a psychotic disorder characterized by functional dysconnectivity or abnormal integration between distant brain regions. Recent functional imaging studies have implicated large-scale thalamo-cortical connectivity as being disrupted in patients. However, observed connectivity differences in schizophrenia have been inconsistent between studies, with reports of hyperconnectivity and hypoconnectivity between the same brain regions. Using resting state eyes-closed functional imaging and independent component analysis on a multi-site data that included 151 schizophrenia patients and 163 age- and gender matched healthy controls, we decomposed the functional brain data into 100 components and identified 47 as functionally relevant intrinsic connectivity networks. We subsequently evaluated group differences in functional network connectivity, both in a static sense, computed as the pairwise Pearson correlations between the full network time courses (5.4 minutes in length), and a dynamic sense, computed using sliding windows (44 s in length) and k-means clustering to characterize five discrete functional connectivity states. Static connectivity analysis revealed that compared to healthy controls, patients show significantly stronger connectivity, i.e., hyperconnectivity, between the thalamus and sensory networks (auditory, motor and visual), as well as reduced connectivity (hypoconnectivity) between sensory networks from all modalities. Dynamic analysis suggests that (1), on average, schizophrenia patients spend much less time than healthy controls in states typified by strong, large-scale connectivity, and (2), that abnormal connectivity patterns are more pronounced during these connectivity states. In particular, states exhibiting cortical-subcortical antagonism (anti-correlations) and strong positive connectivity between sensory networks are those that show the group differences of thalamic hyperconnectivity and sensory hypoconnectivity. Group differences are weak or absent during other connectivity states. Dynamic analysis also revealed hypoconnectivity between the putamen and sensory networks during the same states of thalamic hyperconnectivity; notably, this finding cannot be observed in the static connectivity analysis. Finally, in post-hoc analyses we observed that the relationships between sub-cortical low frequency power and connectivity with sensory networks is altered in patients, suggesting different functional interactions between sub-cortical nuclei and sensorimotor cortex during specific connectivity states. While important differences between patients with schizophrenia and healthy controls have been identified, one should interpret the results with caution given the history of medication in patients. Taken together, our results support and expand current knowledge regarding dysconnectivity in schizophrenia, and strongly advocate the use of dynamic analyses to better account for and understand functional connectivity differences.

1 January 1982 in Schizophrenia Bulletin
Verified
Journal Article
Closed access
HCH. E. Cannon-Spoor
H. E. Cannon-Spoor
SPS. G. Potkin
S. G. Potkin
RWR. J. Wyatt
R. J. Wyatt
The Premorbid Adjustment Scale (PAS) is a rating scale which was developed to be applicable in a research setting. It is designed to evaluate the degree of achievement of developmental goals at each of several periods of a subject's life before the onset of schizophrenia. A description of the scale and its use is presented, along with a discussion of psychometric properties. The PAS has been found to be useful in identifying patients likely to become chronically hospitalized or at high risk for readmission. It may also serve as a possible predictor of patients with brain abnormalities on a computerized tomography (CT) scan.

1 April 1995 in Archives of General Psychiatry
Verified
Journal Article
Closed access
PDF file
SASchahram Akbarian
Schahram Akbarian
JKJames J. Kim
James J. Kim
SPSteven G. Potkin
Steven G. Potkin
JHJennifer O. Hagman
Jennifer O. Hagman
ATAlireza Tafazzoli
Alireza Tafazzoli
EJEdward G. Jones
Edward G. Jones
From JAMA Psychiatry — Gene Expression for Glutamic Acid Decarboxylase Is Reduced Without Loss of Neurons in Prefrontal Cortex of Schizophrenics

24 April 2005 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MTMark H. Tuszynski
Mark H. Tuszynski
LTLeon Thal
Leon Thal
MPMary Pay
Mary Pay
DSDavid P Salmon
David P Salmon
HUHoi Sang U
Hoi Sang U
JCJames Conner
James Conner

8 January 2014 in Brain Imaging and Behavior
Verified
Journal Article
Open access
PDF file
PTPaul M. Thompson
Paul M. Thompson
JSJason L. Stein
Jason L. Stein
SMSarah E. Medland
Sarah E. Medland
DHDerrek P. Hibar
Derrek P. Hibar
AVAlejandro Arias Vasquez
Alejandro Arias Vasquez
WDWayne Drevets
Wayne Drevets
The Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) Consortium is a collaborative network of researchers working together on a range of large-scale studies that integrate data from 70 institutions worldwide. Organized into Working Groups that tackle questions in neuroscience, genetics, and medicine, ENIGMA studies have analyzed neuroimaging data from over 12,826 subjects. In addition, data from 12,171 individuals were provided by the CHARGE consortium for replication of findings, in a total of 24,997 subjects. By meta-analyzing results from many sites, ENIGMA has detected factors that affect the brain that no individual site could detect on its own, and that require larger numbers of subjects than any individual neuroimaging study has currently collected. ENIGMA’s first project was a genome-wide association study identifying common variants in the genome associated with hippocampal volume or intracranial volume. Continuing work is exploring genetic associations with subcortical volumes (ENIGMA2) and white matter microstructure (ENIGMA-DTI). Working groups also focus on understanding how schizophrenia, bipolar illness, major depression and attention deficit/hyperactivity disorder (ADHD) affect the brain. We review the current progress of the ENIGMA Consortium, along with challenges and unexpected discoveries made on the way.

5 August 2005 in International Journal of Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
RLRoger M. Lane
Roger M. Lane
SPSteven G. Potkin
Steven G. Potkin
AEAlbert Enz
Albert Enz
The cholinesterase inhibitors (ChE-Is) attenuate the cholinergic deficit underlying the cognitive and neuropsychiatric dysfunctions in patients with